A phase II study of FOLFIRI-3 (double infusion of irinotecan combined with LV5FU) after FOLFOX in advanced colorectal cancer patients

In advanced colorectal cancer previously treated with oxaliplatin, efficacy of irinotecan-based chemotherapy is poor and the best regimen is not defined. We designed FOLFIRI-3 and conducted a phase II study to establish its efficacy and safety in advanced colorectal cancer patients previously treate...

Descripción completa

Detalles Bibliográficos
Autores principales: Mabro, M, Artru, P, André, T, Flesch, M, Maindrault-Goebel, F, Landi, B, Lledo, G, Plantade, A, Louvet, C, de Gramont, A
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2006
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361413/
https://www.ncbi.nlm.nih.gov/pubmed/16622455
http://dx.doi.org/10.1038/sj.bjc.6603095

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361413/
https://www.ncbi.nlm.nih.gov/pubmed/16622455
http://dx.doi.org/10.1038/sj.bjc.6603095

Ejemplares similares